Active, Not Recruiting A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer NCT06521567 Conditions Adenocarcinoma, Astrocytoma, Brain Diseases, +56 more Locations GSK Investigational Site — Los Angeles, California, United States GSK Investigational Site — Iowa City, Iowa, United States GSK Investigational Site — Hackensack, New Jersey, United States GSK Investigational Site — Cincinnati, Ohio, United States View all 20 locations View more locations Show fewer locations Loading locations... View Trial Details